Table 3. Antibiotic resistance patterns of ESBL- and MBL-producing isolates.
ESBL, extended-spectrum β-lactamase; MBL, metallo-β-lactamase
| Antibiotic | Resistant isolates (%) | Multidrug resistance pattern |
| Ampicillin | 92.3 | ESBL-producing isolates |
| Amoxicillin-clavulanic acid | 84.6 | ESBL-producing isolates |
| Ceftriaxone | 76.9 | ESBL-producing isolates |
| Cefepime | 73.8 | ESBL-producing isolates |
| Ceftazidime | 65.4 | ESBL-producing isolates |
| Ciprofloxacin | 60.0 | MBL-producing isolates |
| Levofloxacin | 57.1 | MBL-producing isolates |
| Gentamicin | 42.9 | MBL-producing isolates |
| Meropenem | 38.1 | MBL-producing isolates |
| Imipenem | 35.7 | MBL-producing isolates |